Joseph R. Holmes, VP and Chief Accounting Officer of Thermo Fisher Scientific Inc., filed a Form 4 on August 10, 2026, disclosing the exercise of 420 stock options and the same-day sale of 420 shares of common stock on August 7, 2026.

Key Highlights

  • Option exercise: Holmes acquired 420 shares of common stock via a stock option exercise (transaction code M) at an exercise price of $309.63 per share on August 7, 2026.
  • Same-day sale: Holmes disposed of 420 shares (transaction code S) at a price of $584.81 per share on August 7, 2026.
  • Remaining direct ownership: Following the transactions, Holmes directly owned 2,966.3555 shares of common stock.
  • Remaining derivative position: Holmes holds 140 stock options (right to buy) with an exercise price of $309.63, expiring February 25, 2027.
  • Option vesting: According to the filing, the exercised option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024.
  • Filing signatory: The form was signed by Melodie T. Morin as Attorney-in-Fact for Joseph R. Holmes and filed on August 10, 2026.

Holmes Option Exercise and Share Sale at Thermo Fisher Scientific

According to the Form 4 filed with the SEC on August 10, 2026, Joseph R. Holmes, identified in the filing as VP and Chief Accounting Officer of Thermo Fisher Scientific Inc. (TMO), reported two transactions in the company's common stock on August 7, 2026. Holmes first exercised a stock option to acquire 420 shares at a conversion or exercise price of $309.63 per share, reported under transaction code M. The same day, Holmes disposed of 420 shares at $584.81 per share, reported under transaction code S.

Prior to the reported transactions, the filing indicates Holmes held 3,386.3555 shares of common stock directly. Following both transactions, direct beneficial ownership of common stock stood at 2,966.3555 shares, as reported in Table I of the filing. The filing notes the option exercised had vested in four equal installments on February 25, 2021, 2022, 2023, and 2024.

In Table II, the filing reports that after the exercise, Holmes retains 140 stock options (right to buy) with an exercise price of $309.63 and an expiration date of February 25, 2027, held directly. The price of the derivative security at exercise is listed as $0, consistent with a standard option exercise transaction. All transactions are reported as direct ownership, with no indirect beneficial ownership reported in this filing.

What Was Disclosed

The filing discloses the exercise of 420 stock options and the same-day sale of 420 shares of Thermo Fisher Scientific common stock by the company's VP and Chief Accounting Officer on August 7, 2026, with 2,966.3555 shares and 140 remaining options held directly afterward.